• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Aminobenzoic acids and derivatives

Professional Introduction to 4-(Dihexylamino)benzoic Acid (CAS No. 134690-32-7)

4-(Dihexylamino)benzoic acid, identified by its Chemical Abstracts Service (CAS) number 134690-32-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound, characterized by its dihexylamino substituent on a benzoic acid backbone, exhibits unique chemical and biological properties that make it a valuable candidate for various applications, particularly in drug development and molecular imaging.

The structure of 4-(Dihexylamino)benzoic acid consists of a benzoic acid core functionalized with a dihexylamino group. This particular arrangement imparts distinct physicochemical properties, including solubility characteristics and interaction profiles with biological targets. The long alkyl chain of the dihexylamino group enhances lipophilicity, which can be advantageous for membrane permeability and cellular uptake in drug formulations.

In recent years, 4-(Dihexylamino)benzoic acid has been explored for its potential in the development of novel therapeutic agents. Its ability to modulate biological pathways has been investigated in several preclinical studies. Notably, research has highlighted its interactions with enzymes and receptors involved in metabolic disorders and neurodegenerative diseases. The compound’s unique pharmacophore has been leveraged to design derivatives with enhanced specificity and efficacy.

One of the most compelling aspects of 4-(Dihexylamino)benzoic acid is its utility in molecular imaging techniques. The compound’s fluorescence properties have been harnessed for the development of probes that can visualize specific biological processes in real-time. These probes are particularly useful in diagnostic applications, where high-resolution imaging is crucial for accurate disease detection and monitoring.

The synthesis of 4-(Dihexylamino)benzoic acid presents unique challenges due to the complexity of its structure. Advanced synthetic methodologies, including multi-step organic transformations and purification techniques, are employed to ensure high yield and purity. Recent advancements in synthetic chemistry have enabled more efficient production processes, making this compound more accessible for research and commercial applications.

The pharmacological profile of 4-(Dihexylamino)benzoic acid has been extensively studied in vitro and in vivo. Preclinical trials have demonstrated its potential as an inhibitor of certain enzymes implicated in inflammation and oxidative stress. These findings have spurred interest in exploring its therapeutic potential for conditions such as arthritis, cardiovascular diseases, and neuroinflammation.

In addition to its pharmaceutical applications, 4-(Dihexylamino)benzoic acid has shown promise in materials science. Its ability to form stable complexes with metal ions has been exploited in the development of novel catalysts and functional materials. These applications highlight the versatility of this compound beyond traditional biomedical contexts.

The future prospects for 4-(Dihexylamino)benzoic acid are vast, driven by ongoing research and technological innovations. As our understanding of biological systems continues to evolve, new applications for this compound are likely to emerge. Collaborative efforts between academia and industry are essential to fully realize its potential in addressing complex challenges in medicine and materials science.

• 77940-94-4(3-(Piperidin-1-yl)benzoic Acid)
• 4740-24-3(4-(Butylamino)benzoic acid)
• 5429-28-7(4-(Diethylamino)benzoic acid)
• 55986-43-1(Cetaben)
• 22090-27-3(4-(Pyrrolidin-1-yl)benzoic acid)
• 72548-79-9(3-(Pyrrolidin-1-yl)benzoic acid)
• 22090-24-0(4-(Piperidin-1-yl)benzoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)